Phat buy sell hold. Bullish or bearish does it have a strong buy signal. Probability of >80% increase 30, 60, 90 days. , ,

**Phathom Pharmaceuticals (PHAT) is currently exhibiting a bearish signal**, as evidenced by the recent price performance and technical indicators. Here's a detailed analysis:

1. **Recent Price Performance**:
- The closing price of PHAT on July 21, 2025, was $7.83, reflecting a decline of 1.51%.
- The stock has experienced a significant surge, over 95%, following FDA approval and the granting of market exclusivity for VOQUEZNA. However, this positive momentum has not been sustained, and the stock is now trading below the 20-day, 30-day, and 50-day moving averages, indicating a bearish trend.

|code|Ticker|Name|Date|Closing Price|market_code|
|---|---|---|---|---|---|
|PHAT|PHAT.O|Phathom|20250721|7.83|185|

|code|Ticker|Name|Date|Moving Average|market_code|
|---|---|---|---|---|---|
|PHAT|PHAT.O|Phathom|20250721|8.1940|185|

2. **Technical Indicators**:
- The MACD (Moving Average Convergence Divergence) is -0.64, which typically suggests bearish momentum as it is below the signal line.
- The RSI (Relative Strength Index) is at 21.21, which is quite low and can indicate that the stock is oversold. However, it also suggests that the stock has been under strong selling pressure.
- The KDJ (Stochastic Oscillator) is at -8.74, which is also below the oversold threshold, indicating a lack of buying momentum.
- The Bollinger Bands are at $9.02, and the current price is below this level, which could be seen as a bearish signal as the stock is trading in the lower part of its recent range.

|code|Ticker|Name|Date|Boll|RSI|KDJ|MACD|market_code|
|---|---|---|---|---|---|---|---|---|
|PHAT|PHAT.O|Phathom|20250721|9.0160|21.2143|-8.7433|-0.6383|185|

3. **Moving Averages**:
- The 5-day, 10-day, and 20-day moving averages are $8.19, $8.73, and $9.02, respectively. The stock is trading below these short-term and medium-term moving averages, which is a bearish indicator.
- The 30-day, 50-day, and 60-day moving averages are $9.31, $7.17, and $6.55, respectively. The stock is also trading below these longer-term moving averages, reinforcing the bearish outlook.

4. **Price Target and Analyst Ratings**:
- The average price target from current price targets set by analysts is $17, which is slightly above the current price but below the high-end analyst target of $28.00. This suggests a potential for a modest increase, but not a strong buy signal.
- The consensus rating is a "Strong Buy", which could indicate potential for growth. However, this needs to be weighed against the current bearish technical indicators.

5. **Fund Flow**:
- There is no available data on net fund flow or block order activity, which makes it difficult to assess the direction of investment inflows or outflows.

**Probability of >80% Increase in 30, 60, 90 Days**:
Given the current technical indicators and price positioning below key moving averages, it is challenging to justify a high probability of an 80% increase within the next 30, 60, or 90 days. The stock's recent performance and the bearish signals from technical indicators suggest caution rather than optimism for a strong bullish movement in the near term.

In conclusion, while there is potential for a modest increase based on the analyst consensus, the current technical indicators and price positioning suggest a bearish outlook, and the probability of a >80% increase within the specified time frames appears low based on the available data. Investors should exercise caution and consider the risks associated with the current market sentiment and technical indicators.